Morari, Inc.

Climax Delay Patch for MOR Intimate Experience

Print
Follow Claim My Business
Categories
Retail, Consumer Goods & Products, Healthcare & Medical, Technology, Health & Fitness
Min Investment
$500
Location
MAPLE GROVE, MN
Expected Close Date
April 30, 2025
Target Raise
$92.00K-$294.04K
No. Investors
45
Security Price
$1.10
Valuation
$7,983,000
Number of Employees
1
Cash
$653,265
Revenue
$0
Short Term Debt
$240,310
Cost of Goods
$0
Long Term Debt
$101,765
Net Income
$-646,440

Key Deal Facts

💵 A unique product in a $37B global sexual health and wellness market
💰 Revenue projected to reach $25M by 2025 (not guaranteed)
🥇First significant innovation in the male sexual health industry since the launch of Viagra in 1998
🦸 Pioneering sexual health company using innovative patented technology
🔬We help men last longer and intensify their climax
🏆Winner of Proctor & Gamble Innovation Challenge and many other awards
✨Global media buzz includes: Daily Mail, CNET, Men’s Health, Forbes, and the Jimmy Kimmel Live show

Management Team / Advisory Board Bios

Jeff Bennett CEO and FounderForward-thinking innovator with more than 25 years of medical device experience. Jeff has led global launches of several high-profile products., Kate LaBrosse Commercial AdvisorOver 14 years' experience in marketing, managing, selling and building natural products brands. Amazon bestselling author on natural healing remedies and advocate for holistic wellbeing., Michael Hoey, PhD Scientific AdvisorSerial entrepreneur having formed and exited multiple companies. Former Professor of Urology., Mark Payne Chief Financial OfficerExperienced CFO with over 30 years of financial experience. Led multiple IPOs and private placements., Sew-Wah Tay, PhD Regualtory/Clinical/Quality AdvisorFounder of Libra Medical. Experienced VP of regulatory, clinical and quality.
Amount Raised : $1,005,037
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments